Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Previous Speakers

S Steve Zhou

S Steve Zhou

Director of Virology and Toxicology at Microbac Laboratories, Inc., USA

Mariusz Z. Ratajczak

Mariusz Z. Ratajczak

Professor University of Louisville, USA

Yoshinori HAYAKAWA

Yoshinori HAYAKAWA

Toin University of Yokohama, Japan

Pierre A. Morgon

Pierre A. Morgon

Department of Pharmacy MRGN Advisors, Switzerland

Robert L Hunter

Robert L Hunter

University of Texas Health Sciences Center, USA

Kenneth W Beagley

Kenneth W Beagley

Queensland University of Technology, Australia

Yusuf Omosun

Yusuf Omosun

Morehouse School of Medicine, USA

Igor S Lukashevich

Igor S Lukashevich

University of Louisville, USA

European Vaccine 2019

About Conference

Vaccine research conference committee is going to welcome all the participants from all over the world to attain the Vaccine Research 2019 conference, which is going to be held in Geneva, Switzerland during November 14-15, 2019. This gathering will give the whole concentration on existing and most recent developments in every aspect of vaccine and antibiotic research. In the light of this subject, this opportunity will provide a great platform for discussing among global scientists from different regions of vaccines, vaccinations, antibiotics and its applications. Therefore, these conference committee members are giving warm welcome all the prominent researchers, students and delegates to participate in this upcoming Vaccine Research conference event to witness a valuable scientific discussion and to participate in this session for contributing to the future innovations in this field.


Target Audience:


  • Heads, Deans and Professors & University Faculty
  • Scientists and Researchers
  • Vaccines and Immunization Associations and Organizations
  • Laboratory members and Students working in this field
  • Physicians in the field of Vaccine and Antibiotics
  • Cancer Specialists & Immune Therapists
  • Nurse Practitioners and Physician Assistants
  • Business Intelligence Experts of Pharmaceutical Industries
  • Vaccine and Antibiotic Manufacturing Companies
  • Vaccine and Antibiotic Developers and Investigators
  • Vaccination Programme Organizing Government and Non-government Organizations




1.Vaccine Types

Vaccines are the most important biological preparations that can provide active acquired immunity against a particular disease. It consists of disease causing microorganism (like bacteria, viruses) or their disease causing substances. There are many kinds of vaccines like Recombinant Vaccines, Live Attenuated Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, and Conjugate Vaccines etc., which can provide the immunization in different manner. Therefore, vaccination is very important process that one should take to be healthy and free from the diseases in future.


  • Vaccine types
  • Vaccine components
  • Vaccine storage and handling

2.Vaccines for Infectious and Non-infectious Diseases

Vaccines are prepared to provide the protection against different kinds of viral diseases like hepatitis, viral cancer, MMR, poliomyelitis, influenza etc., different kinds of bacterial diseases like anthrax, diphtheria, tetanus, tuberculosis, typhoid, cholera and many more. Nowadays parasitic malarial vaccines and non-infectious disease vaccines like DNA vaccines for preventing tumor and allergy are also available. These molecular preparations play very important role to boost the immune system.


3.Plant Vaccination

Plant disease and insect attacks are the significant causes of crop production losses. Plant vaccination is the new approach to protect the crops from the targeted pathogen by spaying double-stranded RNA molecules having similarities with that pathogen’s RNA. Therefore, a novel vaccine can replace the pesticides without putting environment, humans and organisms at risk. Plants are able to produce different classes of proteins having pharmaceutical significance at a high yield that leads to produce low-cost products. Development of plant-derived vaccines against influenza viruses, ebola viruses, rabies virus, flaviviruses and more is the promising avenue in this field.


  • Plant vaccination process
  • Plants as bioreactor for vaccine production
  • Plant-derived vaccines
  • Edible vaccines

4.Veterinary Vaccines

Vaccinations of animals are very important for preventing their diseases and the transmission of diseases to humans. Livestock animals and pets should be routinely vaccinated. Different kinds of veterinary vaccines are there like canine vaccines, feline vaccines, vaccines for dogs, poultry vaccines and more.


  • Canine vaccines
  • Feline vaccines
  • Dog’s vaccines
  • Poultry vaccines
  • Veterinary vaccine  preparations

5.Maternal and Neonatal Vaccination

Vaccination plays an important role for both maternal and neonatal health conditions. It is so beneficial for women to be immunized to reduce chances of morbidity and mortality from vaccine-preventable diseases. Some vaccines should be given to mother before pregnancy, some during pregnancy and some post pregnancy. Neonatal vaccination is the lifetime opportunity to initiate the early protective response against infectious diseases like polio, smallpox etc.


  • Pre-pregnancy vaccination
  • Vaccination during pregnancy
  • Post-pregnancy vaccination
  • Neonatal vaccination


Cancer vaccines can treat existing cancer (therapeutic cancer vaccines) and prevent development of cancers. Some vaccines are autologous or patient specific. Many cancers are caused by oncoviruses like HPV, hepatitis B and also by oncobacteria like Helicobacter pylori. Nowadays, approved oncovaccines like oncophage, Sipuleucel-T are used in many countries for cancer immunotherapy.


  • Therapeutic cancer vaccines
  • Vaccines against oncobacteria
  • Vaccines against oncoviruses

7.Vaccination Advancement

Basically three types of vaccination strategies are used to give vaccines such as pulse vaccination strategy (repeatedly vaccinating over a defined age range), ring vaccination (vaccinating only those who are most likely to be infected) and cocooning (giving booster vaccines to mothers, family members to protect new-born babies becoming infected by them).

Vaccine trial or clinical trials are required for the safety and efficacy of the vaccines. Four different phases of trials are present in trial methodology as phase one, phase two, phase three and phase four.

Different types of viral, bacterial, parasitic and non-infectious disease vaccines are under research at present time like zika, adenovirus, hepatitis c, leprosy, chagas disease, Alzheimer’s disease and so on.


  • Pulse vaccination
  • Ring vaccination
  • Cocooning
  • Different phases of vaccine trials
  • Recent advancements in vaccine development
  • Reverse vaccinology


Antibiotics are the most important antimicrobial agents for fighting against bacterial, fungal activities or infections. Three types of antibiotics are found as natural antibiotics which are produced by natural microorganisms via fermentation, semi-synthetic antibiotics that can be prepared by using natural fermentation process with chemical combination and synthetic antibiotics which are completely prepared in laboratory synthetically.


  • Natural, semi-synthetic and synthetic antibiotics and their productions
  • Antibiotics against bacterial infection
  • Antibiotics against fungal infection
  • Classes of antibiotics

9.Pharmacokinetics & Pharmacodynamics of Antibiotics

The pharmacokinetic (movement of drugs) and pharmacodynamic (efficacy and toxicity of drugs at specific site of action) properties of the antibiotics are the key factors for successful working activity. This is the relationship between concentration of antibiotic and its ability to inhibit vital processes of microbial organisms. The pharmacodynamics of an antibiotic relates its pharmacokinetics to the time course of the antimicrobial activity at the site of the infection.


  • Pharmacokinetics of different antibiotics
  • Pharmacodynamics of different antibiotics
  • Minimum inhibitory concentration (MIC)

10.RDT in Antibiotic Research

The industrial antibiotic yield has been enhanced by technological innovations and the development of strain improvement of microorganisms through random mutation and screening. The recombinant DNA technology and its application in antibiotic production by microorganisms have given yield enhancement and design of biosynthetic pathways for new antibiotic production. Genetic manipulation of biosynthetic pathways is very useful process for producing antagonistic products of complex bioactive metabolites.

11.Antibiotic Resistance

The resistance of bacteria or microbes to antibiotics is very common phenomenon. Though survival of microbe results from an inheritable resistance but the growth of resistance to antibiotics also occurs through horizontal gene transfer, which is more likely to occur for frequent antibiotic use. Antibacterial-resistant strains and species are called superbugs in some cases like E. coli bacteria superbug, multidrug-resistant tuberculosis.


  • Horizontal gene transfer for resistance to antibiotics
  • Antibacterial-resistant strains and species
  • E. coli bacteria superbug
  • Multidrug-resistant tuberculosis

12.Antibiotics Advancement

Due to antimicrobial resistance phenomenon, some infectious microbes become untreatable. Various efforts have been made to develop the next generation antibiotics with novel action mechanisms which can combat against the multi-drug resistant strains of microbes. Recently, symbiotic bacteria are also used to produce antibiotics against MDR strains like odilorhabdins (ODLs).


13.Side-effects of Antibiotics & Vaccines

Antibiotics are screened for side effects before getting the approval for clinical use. Some antibiotics have mild to severe side effects depending on the type of antibiotic used, targeted microbes and the individual patient. Vaccines have normally less harmful side effects like mild fever, headache, muscle joint pain; shivering etc. but few vaccines have rare side effects like allergy known as anaphylactic reaction.


  • New antibiotics, their side effects and challenges to use
  •  New vaccines, their side effects and challenges to use

14.Nanotechnology in Antibiotics, Vaccines Development

Nowadays, drug-resistant bacteria can be killed by using antibiotic nanoparticles. Light activated nanoparticles can make existing antibiotics more effective for treatment of antibiotic resistance microbes. Metal oxide nanoparticles are now used as antibacterial agents. Nanocarriers such as liposomes, polymeric particles, virosomes, lipid nanoparticles etc. can help in improving the immunogenicity of new generation vaccines and protect the vaccines against degradation also.


  • Antibiotic nanoparticles
  • Metal oxide nanoparticles as antibacterial agents
  • Nanocarriers used for next generation vaccination

15.Regulatory Affairs

Regulatory affairs which is also known as government affairs, is a professional aspect within regulated industries, such as medical devices, functional foods, biologics and pharmaceutical companies. Regulatory affairs (medical affairs) handling personnel generally has the duty for these areas like ensuring that the companies obey with all of the regulations and laws pertaining to their business and protecting public health by controlling the safety and efficacy of the products.


Market Analysis

The worldwide markets of vaccines and antibiotics are expected to grow because of factors like increasing prevalence of chronic diseases, growing healthcare expenditure, improvement in access to healthcare, high investment in research & development, enhancements of supports from government and stakeholders such as UNICEF, WHO, PAHO and others. According to the Ameri Research Inc., market of global vaccines was valued at $32 billion in 2016 and is anticipated to reach $61.6 billion by 2024. The human vaccine market in all over the world is predicted to reach more than $47.5 billion by 2022 with the varied demand for vaccines in high-income and developing countries.

According to Kalorama’s new report, the European vaccine market covers only commercialized vaccines and developmental vaccines for diseases that are already vaccine-preventable. The emerging vaccines are not covered for diseases that are not currently vaccine-preventable, such as Alzheimer’s disease, diabetes, Ebola infection, Epstein-Barr virus (EBV) infection, heart attack, Helicobacter pylori infection, Parkinson’s disease, etc.

The worldwide demand for antibiotics has increased significantly over the past two decades. The antibiotics market was valued at about $40,866 million in 2017, which is estimated to register a compound annual growth rate (CAGR) of 4.7%, over the forecast period of 2018 to 2023. There are a range of global pharmaceutical companies, as well as smaller firms which plays an important role in domestic regions in the production of generic drugs. Most of the antibiotics are low-cost and off-patent generic medicines which are easily and widely affordable, especially among the low income and lower-middle-income countries. In addition, the generic industries play a major role in the cost reduction of pharmaceutical drugs, which increase consumption and higher availability in worldwide.


Past Conference Report

Euro Vaccines 2018 Report

The 31st Euro Global Summit and Expo on Vaccines & Vaccination hosted by Conferenceseries LLC Ltd during June 14-16, 2018 at TRYP BARCELONA AEROPUERTO, Barcelona, Spain with a theme “Roadmap on the future of Vaccines Research” and was a great success where eminent Keynote Speakers, Speakers, Delegates and Poster Presenters from various reputed companies and Universities made their resplendent presence and addressed the gathering.

Euro Vaccines 2018 witnessed an amalgamation of peerless speakers who enlightened the crowd with their knowledge and confabulated on various new-fangled topics related to the field of Vaccines and Therapeutics.

We would like to convey a great appreciation to following eminent people, honorable guests and Keynote speakers.

Gabriel Kristian Pedersen, Statens Serum Institut, Denmark

Carmen Alvarez-Dominguez, Instituto de Investigación Marqués de Valdecilla, Spain

Frederic J Deschamps, University Hospital of Reims, France

Randa S Hamadeh, Ministry of Public Health, Lebanon

Special thanks to our Honorable Moderator, Dr. Frederic J Deschamps for his remarkable contribution towards smooth functioning at Euro Vaccines 2018 Conference.

Conferenceseries LLC Ltd on behalf of the conference congratulates the Best Poster awardees for their outstanding performance and appreciates all the participants who put their efforts in presentations and sincerely wishes them success in future endeavours.

Conferenceseries LLC Ltd would like to convey a warm gratitude to Chairs and Co-chairs who contributed effervescently for the smooth functioning of the event, Frederic J Deschamps, University Hospital of Reims, France and Chit Laa Poh, Sunway University, Malaysia.

Euro Vaccines 2018 conference was a great success with the support of International multi professional steering committee and coordinated by Journal of Vaccines & Vaccination, Journal of Clinical & Cellular Immunology and Immunome Research.

Our sincere thanks to Organizing Committee Members for their gracious presence, support and assistance towards Euro Vaccines 2018 conference and with the enormous feedback from the participants and supporters of Euro Vaccines 2018, Conferenceseries LLC Ltd is glad to announce 2nd International Conference on Vaccines Research, November 14-15, 2019, Geneva, Switzerland.

VISA Application

Vaccine Research 2019 organizing committee hereby reiterates that we are NOT authorized to assist with any Visa application works. You may be required to submit a Letter of Invitation, Letter of Abstract Acceptance and Registration Payment Receipt to the embassy.

Letter of Invitation: A Letter of Invitation is a proof that your paper submission and registration application are accepted by the conference committee board. It will be stated in English and may help with your visa application. 

Token Amount: Token amount of USD 100 can be paid and payment receipt can be a proof for payment and may help with your VISA application.  



To Collaborate Scientific Professionals around the World

Conference Date November 14-15, 2019

For Sponsors & Exhibitors

Speaker Opportunity

Past Conference Report

Supported By

Journal Of Vaccines & Vaccination Journal of clinical & cellular Immunology Immunome Research

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by

Past Affiliations

Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos